vs
Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and INSTEEL INDUSTRIES INC (IIIN). Click either name above to swap in a different company.
COLLEGIUM PHARMACEUTICAL, INC is the larger business by last-quarter revenue ($205.4M vs $159.9M, roughly 1.3× INSTEEL INDUSTRIES INC). COLLEGIUM PHARMACEUTICAL, INC runs the higher net margin — 8.3% vs 4.7%, a 3.5% gap on every dollar of revenue. On growth, INSTEEL INDUSTRIES INC posted the faster year-over-year revenue change (23.3% vs 12.9%). COLLEGIUM PHARMACEUTICAL, INC produced more free cash flow last quarter ($122.4M vs $-2.2M). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs 12.0%).
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.
Insteel Industries Inc is a leading U.S. manufacturer of steel reinforcing products including welded wire reinforcement and steel fibers. It primarily serves non-residential construction, infrastructure, and precast concrete segments across North America, delivering high-performance reinforcement solutions for various construction projects.
COLL vs IIIN — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $205.4M | $159.9M |
| Net Profit | $17.0M | $7.6M |
| Gross Margin | 62.5% | 11.3% |
| Operating Margin | 29.6% | 6.0% |
| Net Margin | 8.3% | 4.7% |
| Revenue YoY | 12.9% | 23.3% |
| Net Profit YoY | 35.3% | 602.4% |
| EPS (diluted) | $0.48 | $0.39 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $205.4M | $159.9M | ||
| Q3 25 | $209.4M | $177.4M | ||
| Q2 25 | $188.0M | $179.9M | ||
| Q1 25 | $177.8M | $160.7M | ||
| Q4 24 | $181.9M | $129.7M | ||
| Q3 24 | $159.3M | $134.3M | ||
| Q2 24 | $145.3M | $145.8M | ||
| Q1 24 | $144.9M | $127.4M |
| Q4 25 | $17.0M | $7.6M | ||
| Q3 25 | $31.5M | $14.6M | ||
| Q2 25 | $12.0M | $15.2M | ||
| Q1 25 | $2.4M | $10.2M | ||
| Q4 24 | $12.5M | $1.1M | ||
| Q3 24 | $9.3M | $4.7M | ||
| Q2 24 | $19.6M | $6.6M | ||
| Q1 24 | $27.7M | $6.9M |
| Q4 25 | 62.5% | 11.3% | ||
| Q3 25 | 61.7% | 16.1% | ||
| Q2 25 | 57.7% | 17.1% | ||
| Q1 25 | 54.8% | 15.3% | ||
| Q4 24 | 54.0% | 7.3% | ||
| Q3 24 | 60.8% | 9.1% | ||
| Q2 24 | 62.5% | 10.6% | ||
| Q1 24 | 63.1% | 12.3% |
| Q4 25 | 29.6% | 6.0% | ||
| Q3 25 | 29.7% | 10.8% | ||
| Q2 25 | 18.7% | 11.0% | ||
| Q1 25 | 12.2% | 8.3% | ||
| Q4 24 | 20.9% | 1.1% | ||
| Q3 24 | 21.9% | 4.5% | ||
| Q2 24 | 32.7% | 6.0% | ||
| Q1 24 | 34.1% | 7.0% |
| Q4 25 | 8.3% | 4.7% | ||
| Q3 25 | 15.0% | 8.2% | ||
| Q2 25 | 6.4% | 8.4% | ||
| Q1 25 | 1.4% | 6.4% | ||
| Q4 24 | 6.9% | 0.8% | ||
| Q3 24 | 5.9% | 3.5% | ||
| Q2 24 | 13.5% | 4.5% | ||
| Q1 24 | 19.1% | 5.4% |
| Q4 25 | $0.48 | $0.39 | ||
| Q3 25 | $0.84 | $0.74 | ||
| Q2 25 | $0.34 | $0.78 | ||
| Q1 25 | $0.07 | $0.52 | ||
| Q4 24 | $0.36 | $0.06 | ||
| Q3 24 | $0.27 | $0.24 | ||
| Q2 24 | $0.52 | $0.34 | ||
| Q1 24 | $0.71 | $0.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $386.7M | $15.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $301.7M | $358.8M |
| Total Assets | $1.7B | $456.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $386.7M | $15.6M | ||
| Q3 25 | $285.9M | $38.6M | ||
| Q2 25 | $222.2M | $53.7M | ||
| Q1 25 | $197.8M | $28.4M | ||
| Q4 24 | $162.8M | $36.0M | ||
| Q3 24 | $120.0M | $111.5M | ||
| Q2 24 | $271.6M | $97.7M | ||
| Q1 24 | $318.0M | $83.9M |
| Q4 25 | $301.7M | $358.8M | ||
| Q3 25 | $274.8M | $371.5M | ||
| Q2 25 | $232.2M | $356.2M | ||
| Q1 25 | $234.4M | $341.4M | ||
| Q4 24 | $228.8M | $331.6M | ||
| Q3 24 | $234.3M | $350.9M | ||
| Q2 24 | $216.6M | $346.0M | ||
| Q1 24 | $222.2M | $340.6M |
| Q4 25 | $1.7B | $456.1M | ||
| Q3 25 | $1.6B | $462.6M | ||
| Q2 25 | $1.6B | $471.9M | ||
| Q1 25 | $1.6B | $421.9M | ||
| Q4 24 | $1.7B | $404.7M | ||
| Q3 24 | $1.6B | $422.6M | ||
| Q2 24 | $1.1B | $414.6M | ||
| Q1 24 | $1.1B | $397.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $123.0M | $-701.0K |
| Free Cash FlowOCF − Capex | $122.4M | $-2.2M |
| FCF MarginFCF / Revenue | 59.6% | -1.4% |
| Capex IntensityCapex / Revenue | 0.3% | 0.9% |
| Cash ConversionOCF / Net Profit | 7.25× | -0.09× |
| TTM Free Cash FlowTrailing 4 quarters | $327.6M | $439.0K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $123.0M | $-701.0K | ||
| Q3 25 | $78.4M | $-17.0M | ||
| Q2 25 | $72.4M | $28.5M | ||
| Q1 25 | $55.4M | $-3.3M | ||
| Q4 24 | $84.6M | $19.0M | ||
| Q3 24 | $-9.0M | $16.2M | ||
| Q2 24 | $67.4M | $18.8M | ||
| Q1 24 | $61.9M | $1.4M |
| Q4 25 | $122.4M | $-2.2M | ||
| Q3 25 | $78.3M | $-18.7M | ||
| Q2 25 | $72.4M | $26.9M | ||
| Q1 25 | $54.6M | $-5.5M | ||
| Q4 24 | $84.1M | $16.3M | ||
| Q3 24 | $-9.2M | $14.5M | ||
| Q2 24 | $67.1M | $15.5M | ||
| Q1 24 | $61.4M | $-580.0K |
| Q4 25 | 59.6% | -1.4% | ||
| Q3 25 | 37.4% | -10.6% | ||
| Q2 25 | 38.5% | 15.0% | ||
| Q1 25 | 30.7% | -3.5% | ||
| Q4 24 | 46.2% | 12.6% | ||
| Q3 24 | -5.8% | 10.8% | ||
| Q2 24 | 46.2% | 10.7% | ||
| Q1 24 | 42.3% | -0.5% |
| Q4 25 | 0.3% | 0.9% | ||
| Q3 25 | 0.1% | 1.0% | ||
| Q2 25 | 0.0% | 0.9% | ||
| Q1 25 | 0.4% | 1.4% | ||
| Q4 24 | 0.3% | 2.1% | ||
| Q3 24 | 0.2% | 1.3% | ||
| Q2 24 | 0.2% | 2.2% | ||
| Q1 24 | 0.4% | 1.5% |
| Q4 25 | 7.25× | -0.09× | ||
| Q3 25 | 2.49× | -1.17× | ||
| Q2 25 | 6.05× | 1.88× | ||
| Q1 25 | 22.92× | -0.32× | ||
| Q4 24 | 6.75× | 17.56× | ||
| Q3 24 | -0.96× | 3.48× | ||
| Q2 24 | 3.44× | 2.86× | ||
| Q1 24 | 2.23× | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
COLL
Segment breakdown not available.
IIIN
| Welded Wire Reinforcement | $108.4M | 68% |
| PC Strand | $51.6M | 32% |
